Login / Signup

Difference in the plasma level of miR-628-3p in atopic dermatitis patients with/without atopic keratoconjunctivitis.

Mayumi UetaHiromi NishigakiSeitaro KomaiChie SotozonoShigeru Kinoshita
Published in: Immunity, inflammation and disease (2021)
Our new findings suggest that the plasma miR-628-3p level may represent a marker to predict the presence of severe AKC in AD patients.
Keyphrases
  • atopic dermatitis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • early onset
  • patient reported outcomes